Foresight Acquisition Corp. (FORE) to Combine with P3 Health Partners in $2.3Bn Deal

Foresight (NASDAQ:FORE) has entered into a definitive agreement to combine with healthcare provider P3 at an enterprise value of $2.29 billion, or 2.8x its 2022E revenue. The Nevada-based company provides care to patients in four states through the Medicare Advantage program. The combined company is expected to trade on the Nasdaq upon the deal’s completion
Read More